世界の上肢障害治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Upper Extremities Disorders Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4999
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、上肢障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（置換＆骨折、神経疾患、軟部組織損傷）、用途別市場規模（病院・外科センター、整形外科センター、外科医院）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・上肢障害治療の市場動向
・企業の競争状況、市場シェア
・上肢障害治療の種類別市場規模と予測2016-2027（置換＆骨折、神経疾患、軟部組織損傷）
・上肢障害治療の用途別市場規模と予測2016-2027（病院・外科センター、整形外科センター、外科医院）
・上肢障害治療の北米市場規模2016-2027（アメリカ、カナダ）
・上肢障害治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・上肢障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・上肢障害治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・上肢障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Integra LifeSciences、DePuy Synthes、Stryker、Zimmer Biomet、Smith and Nephew、Wright Medical Group N.V.、Exactech、Arthrex、CONMED Corporation、Acumed、Bioretec、Advanced Orthopaedic Solutions）
・結論

The upper extremities are multi-layered sheath-like parts formed by bones, muscles, vascular nerves, and superficial, deep fascia and skin. Can be divided into shallow and deep two-layer structure. Symptoms of upper extremity disease may include reduced ability to use the affected parts of the limb, pain, and limited speed or range of movement. The upper limbs have important functions for human activities, so patients with upper limb injuries usually need the help of a family doctor

Market Analysis and Insights: Global Upper Extremities Disorders Treatment Market
The global Upper Extremities Disorders Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Upper Extremities Disorders Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Upper Extremities Disorders Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Upper Extremities Disorders Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Upper Extremities Disorders Treatment market.

Global Upper Extremities Disorders Treatment Scope and Market Size
Upper Extremities Disorders Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Upper Extremities Disorders Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Replacement and Fracture
Nerve Diseases
Soft Issue Injuries

Segment by Application
Hospitals and Surgical Centers
Orthopedic Surgical Centers
Ambulatory Surgical Centers

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Integra LifeSciences
DePuy Synthes
Stryker
Zimmer Biomet
Smith and Nephew
Wright Medical Group N.V.
Exactech
Arthrex
CONMED Corporation
Acumed
Bioretec
Advanced Orthopaedic Solutions

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Upper Extremities Disorders Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Replacement and Fracture
1.2.3 Nerve Diseases
1.2.4 Soft Issue Injuries
1.3 Market by Application
1.3.1 Global Upper Extremities Disorders Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Surgical Centers
1.3.3 Orthopedic Surgical Centers
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Upper Extremities Disorders Treatment Market Perspective (2016-2027)
2.2 Upper Extremities Disorders Treatment Growth Trends by Regions
2.2.1 Upper Extremities Disorders Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Upper Extremities Disorders Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Upper Extremities Disorders Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Upper Extremities Disorders Treatment Industry Dynamic
2.3.1 Upper Extremities Disorders Treatment Market Trends
2.3.2 Upper Extremities Disorders Treatment Market Drivers
2.3.3 Upper Extremities Disorders Treatment Market Challenges
2.3.4 Upper Extremities Disorders Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Upper Extremities Disorders Treatment Players by Revenue
3.1.1 Global Top Upper Extremities Disorders Treatment Players by Revenue (2016-2021)
3.1.2 Global Upper Extremities Disorders Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Upper Extremities Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Upper Extremities Disorders Treatment Revenue
3.4 Global Upper Extremities Disorders Treatment Market Concentration Ratio
3.4.1 Global Upper Extremities Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Upper Extremities Disorders Treatment Revenue in 2020
3.5 Upper Extremities Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Upper Extremities Disorders Treatment Product Solution and Service
3.7 Date of Enter into Upper Extremities Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Upper Extremities Disorders Treatment Breakdown Data by Type
4.1 Global Upper Extremities Disorders Treatment Historic Market Size by Type (2016-2021)
4.2 Global Upper Extremities Disorders Treatment Forecasted Market Size by Type (2022-2027)

5 Upper Extremities Disorders Treatment Breakdown Data by Application
5.1 Global Upper Extremities Disorders Treatment Historic Market Size by Application (2016-2021)
5.2 Global Upper Extremities Disorders Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Upper Extremities Disorders Treatment Market Size (2016-2027)
6.2 North America Upper Extremities Disorders Treatment Market Size by Type
6.2.1 North America Upper Extremities Disorders Treatment Market Size by Type (2016-2021)
6.2.2 North America Upper Extremities Disorders Treatment Market Size by Type (2022-2027)
6.2.3 North America Upper Extremities Disorders Treatment Market Size by Type (2016-2027)
6.3 North America Upper Extremities Disorders Treatment Market Size by Application
6.3.1 North America Upper Extremities Disorders Treatment Market Size by Application (2016-2021)
6.3.2 North America Upper Extremities Disorders Treatment Market Size by Application (2022-2027)
6.3.3 North America Upper Extremities Disorders Treatment Market Size by Application (2016-2027)
6.4 North America Upper Extremities Disorders Treatment Market Size by Country
6.4.1 North America Upper Extremities Disorders Treatment Market Size by Country (2016-2021)
6.4.2 North America Upper Extremities Disorders Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Upper Extremities Disorders Treatment Market Size (2016-2027)
7.2 Europe Upper Extremities Disorders Treatment Market Size by Type
7.2.1 Europe Upper Extremities Disorders Treatment Market Size by Type (2016-2021)
7.2.2 Europe Upper Extremities Disorders Treatment Market Size by Type (2022-2027)
7.2.3 Europe Upper Extremities Disorders Treatment Market Size by Type (2016-2027)
7.3 Europe Upper Extremities Disorders Treatment Market Size by Application
7.3.1 Europe Upper Extremities Disorders Treatment Market Size by Application (2016-2021)
7.3.2 Europe Upper Extremities Disorders Treatment Market Size by Application (2022-2027)
7.3.3 Europe Upper Extremities Disorders Treatment Market Size by Application (2016-2027)
7.4 Europe Upper Extremities Disorders Treatment Market Size by Country
7.4.1 Europe Upper Extremities Disorders Treatment Market Size by Country (2016-2021)
7.4.2 Europe Upper Extremities Disorders Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Upper Extremities Disorders Treatment Market Size (2016-2027)
8.2 Asia-Pacific Upper Extremities Disorders Treatment Market Size by Type
8.2.1 Asia-Pacific Upper Extremities Disorders Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Upper Extremities Disorders Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Upper Extremities Disorders Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Upper Extremities Disorders Treatment Market Size by Application
8.3.1 Asia-Pacific Upper Extremities Disorders Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Upper Extremities Disorders Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Upper Extremities Disorders Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Upper Extremities Disorders Treatment Market Size by Region
8.4.1 Asia-Pacific Upper Extremities Disorders Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Upper Extremities Disorders Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Upper Extremities Disorders Treatment Market Size (2016-2027)
9.2 Latin America Upper Extremities Disorders Treatment Market Size by Type
9.2.1 Latin America Upper Extremities Disorders Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Upper Extremities Disorders Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Upper Extremities Disorders Treatment Market Size by Type (2016-2027)
9.3 Latin America Upper Extremities Disorders Treatment Market Size by Application
9.3.1 Latin America Upper Extremities Disorders Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Upper Extremities Disorders Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Upper Extremities Disorders Treatment Market Size by Application (2016-2027)
9.4 Latin America Upper Extremities Disorders Treatment Market Size by Country
9.4.1 Latin America Upper Extremities Disorders Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Upper Extremities Disorders Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Upper Extremities Disorders Treatment Market Size (2016-2027)
10.2 Middle East & Africa Upper Extremities Disorders Treatment Market Size by Type
10.2.1 Middle East & Africa Upper Extremities Disorders Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Upper Extremities Disorders Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Upper Extremities Disorders Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Upper Extremities Disorders Treatment Market Size by Application
10.3.1 Middle East & Africa Upper Extremities Disorders Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Upper Extremities Disorders Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Upper Extremities Disorders Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Upper Extremities Disorders Treatment Market Size by Country
10.4.1 Middle East & Africa Upper Extremities Disorders Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Upper Extremities Disorders Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Integra LifeSciences
11.1.1 Integra LifeSciences Company Details
11.1.2 Integra LifeSciences Business Overview
11.1.3 Integra LifeSciences Upper Extremities Disorders Treatment Introduction
11.1.4 Integra LifeSciences Revenue in Upper Extremities Disorders Treatment Business (2016-2021)
11.1.5 Integra LifeSciences Recent Development
11.2 DePuy Synthes
11.2.1 DePuy Synthes Company Details
11.2.2 DePuy Synthes Business Overview
11.2.3 DePuy Synthes Upper Extremities Disorders Treatment Introduction
11.2.4 DePuy Synthes Revenue in Upper Extremities Disorders Treatment Business (2016-2021)
11.2.5 DePuy Synthes Recent Development
11.3 Stryker
11.3.1 Stryker Company Details
11.3.2 Stryker Business Overview
11.3.3 Stryker Upper Extremities Disorders Treatment Introduction
11.3.4 Stryker Revenue in Upper Extremities Disorders Treatment Business (2016-2021)
11.3.5 Stryker Recent Development
11.4 Zimmer Biomet
11.4.1 Zimmer Biomet Company Details
11.4.2 Zimmer Biomet Business Overview
11.4.3 Zimmer Biomet Upper Extremities Disorders Treatment Introduction
11.4.4 Zimmer Biomet Revenue in Upper Extremities Disorders Treatment Business (2016-2021)
11.4.5 Zimmer Biomet Recent Development
11.5 Smith and Nephew
11.5.1 Smith and Nephew Company Details
11.5.2 Smith and Nephew Business Overview
11.5.3 Smith and Nephew Upper Extremities Disorders Treatment Introduction
11.5.4 Smith and Nephew Revenue in Upper Extremities Disorders Treatment Business (2016-2021)
11.5.5 Smith and Nephew Recent Development
11.6 Wright Medical Group N.V.
11.6.1 Wright Medical Group N.V. Company Details
11.6.2 Wright Medical Group N.V. Business Overview
11.6.3 Wright Medical Group N.V. Upper Extremities Disorders Treatment Introduction
11.6.4 Wright Medical Group N.V. Revenue in Upper Extremities Disorders Treatment Business (2016-2021)
11.6.5 Wright Medical Group N.V. Recent Development
11.7 Exactech
11.7.1 Exactech Company Details
11.7.2 Exactech Business Overview
11.7.3 Exactech Upper Extremities Disorders Treatment Introduction
11.7.4 Exactech Revenue in Upper Extremities Disorders Treatment Business (2016-2021)
11.7.5 Exactech Recent Development
11.8 Arthrex
11.8.1 Arthrex Company Details
11.8.2 Arthrex Business Overview
11.8.3 Arthrex Upper Extremities Disorders Treatment Introduction
11.8.4 Arthrex Revenue in Upper Extremities Disorders Treatment Business (2016-2021)
11.8.5 Arthrex Recent Development
11.9 CONMED Corporation
11.9.1 CONMED Corporation Company Details
11.9.2 CONMED Corporation Business Overview
11.9.3 CONMED Corporation Upper Extremities Disorders Treatment Introduction
11.9.4 CONMED Corporation Revenue in Upper Extremities Disorders Treatment Business (2016-2021)
11.9.5 CONMED Corporation Recent Development
11.10 Acumed
11.10.1 Acumed Company Details
11.10.2 Acumed Business Overview
11.10.3 Acumed Upper Extremities Disorders Treatment Introduction
11.10.4 Acumed Revenue in Upper Extremities Disorders Treatment Business (2016-2021)
11.10.5 Acumed Recent Development
11.11 Bioretec
11.11.1 Bioretec Company Details
11.11.2 Bioretec Business Overview
11.11.3 Bioretec Upper Extremities Disorders Treatment Introduction
11.11.4 Bioretec Revenue in Upper Extremities Disorders Treatment Business (2016-2021)
11.11.5 Bioretec Recent Development
11.12 Advanced Orthopaedic Solutions
11.12.1 Advanced Orthopaedic Solutions Company Details
11.12.2 Advanced Orthopaedic Solutions Business Overview
11.12.3 Advanced Orthopaedic Solutions Upper Extremities Disorders Treatment Introduction
11.12.4 Advanced Orthopaedic Solutions Revenue in Upper Extremities Disorders Treatment Business (2016-2021)
11.12.5 Advanced Orthopaedic Solutions Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Upper Extremities Disorders Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Replacement and Fracture
Table 3. Key Players of Nerve Diseases
Table 4. Key Players of Soft Issue Injuries
Table 5. Global Upper Extremities Disorders Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Upper Extremities Disorders Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Upper Extremities Disorders Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Upper Extremities Disorders Treatment Market Share by Regions (2016-2021)
Table 9. Global Upper Extremities Disorders Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Upper Extremities Disorders Treatment Market Share by Regions (2022-2027)
Table 11. Upper Extremities Disorders Treatment Market Trends
Table 12. Upper Extremities Disorders Treatment Market Drivers
Table 13. Upper Extremities Disorders Treatment Market Challenges
Table 14. Upper Extremities Disorders Treatment Market Restraints
Table 15. Global Upper Extremities Disorders Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Upper Extremities Disorders Treatment Market Share by Players (2016-2021)
Table 17. Global Top Upper Extremities Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Upper Extremities Disorders Treatment as of 2020)
Table 18. Ranking of Global Top Upper Extremities Disorders Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Upper Extremities Disorders Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Upper Extremities Disorders Treatment Product Solution and Service
Table 22. Date of Enter into Upper Extremities Disorders Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Upper Extremities Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Upper Extremities Disorders Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Upper Extremities Disorders Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Upper Extremities Disorders Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Upper Extremities Disorders Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Upper Extremities Disorders Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Upper Extremities Disorders Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Upper Extremities Disorders Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Upper Extremities Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Upper Extremities Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Upper Extremities Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Upper Extremities Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Upper Extremities Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Upper Extremities Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Upper Extremities Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Upper Extremities Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Upper Extremities Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Upper Extremities Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Upper Extremities Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Upper Extremities Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Upper Extremities Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Upper Extremities Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Upper Extremities Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Upper Extremities Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Upper Extremities Disorders Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Upper Extremities Disorders Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Upper Extremities Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Upper Extremities Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Upper Extremities Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Upper Extremities Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Upper Extremities Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Upper Extremities Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Upper Extremities Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Upper Extremities Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Upper Extremities Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Upper Extremities Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Upper Extremities Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Upper Extremities Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Integra LifeSciences Company Details
Table 63. Integra LifeSciences Business Overview
Table 64. Integra LifeSciences Upper Extremities Disorders Treatment Product
Table 65. Integra LifeSciences Revenue in Upper Extremities Disorders Treatment Business (2016-2021) & (US$ Million)
Table 66. Integra LifeSciences Recent Development
Table 67. DePuy Synthes Company Details
Table 68. DePuy Synthes Business Overview
Table 69. DePuy Synthes Upper Extremities Disorders Treatment Product
Table 70. DePuy Synthes Revenue in Upper Extremities Disorders Treatment Business (2016-2021) & (US$ Million)
Table 71. DePuy Synthes Recent Development
Table 72. Stryker Company Details
Table 73. Stryker Business Overview
Table 74. Stryker Upper Extremities Disorders Treatment Product
Table 75. Stryker Revenue in Upper Extremities Disorders Treatment Business (2016-2021) & (US$ Million)
Table 76. Stryker Recent Development
Table 77. Zimmer Biomet Company Details
Table 78. Zimmer Biomet Business Overview
Table 79. Zimmer Biomet Upper Extremities Disorders Treatment Product
Table 80. Zimmer Biomet Revenue in Upper Extremities Disorders Treatment Business (2016-2021) & (US$ Million)
Table 81. Zimmer Biomet Recent Development
Table 82. Smith and Nephew Company Details
Table 83. Smith and Nephew Business Overview
Table 84. Smith and Nephew Upper Extremities Disorders Treatment Product
Table 85. Smith and Nephew Revenue in Upper Extremities Disorders Treatment Business (2016-2021) & (US$ Million)
Table 86. Smith and Nephew Recent Development
Table 87. Wright Medical Group N.V. Company Details
Table 88. Wright Medical Group N.V. Business Overview
Table 89. Wright Medical Group N.V. Upper Extremities Disorders Treatment Product
Table 90. Wright Medical Group N.V. Revenue in Upper Extremities Disorders Treatment Business (2016-2021) & (US$ Million)
Table 91. Wright Medical Group N.V. Recent Development
Table 92. Exactech Company Details
Table 93. Exactech Business Overview
Table 94. Exactech Upper Extremities Disorders Treatment Product
Table 95. Exactech Revenue in Upper Extremities Disorders Treatment Business (2016-2021) & (US$ Million)
Table 96. Exactech Recent Development
Table 97. Arthrex Company Details
Table 98. Arthrex Business Overview
Table 99. Arthrex Revenue in Upper Extremities Disorders Treatment Business (2016-2021) & (US$ Million)
Table 100. Arthrex Recent Development
Table 101. CONMED Corporation Company Details
Table 102. CONMED Corporation Business Overview
Table 103. CONMED Corporation Upper Extremities Disorders Treatment Product
Table 104. CONMED Corporation Revenue in Upper Extremities Disorders Treatment Business (2016-2021) & (US$ Million)
Table 105. CONMED Corporation Recent Development
Table 106. Acumed Company Details
Table 107. Acumed Business Overview
Table 108. Acumed Upper Extremities Disorders Treatment Product
Table 109. Acumed Revenue in Upper Extremities Disorders Treatment Business (2016-2021) & (US$ Million)
Table 110. Acumed Recent Development
Table 111. Bioretec Company Details
Table 112. Bioretec Business Overview
Table 113. Bioretec Upper Extremities Disorders Treatment Product
Table 114. Bioretec Revenue in Upper Extremities Disorders Treatment Business (2016-2021) & (US$ Million)
Table 115. Bioretec Recent Development
Table 116. Advanced Orthopaedic Solutions Company Details
Table 117. Advanced Orthopaedic Solutions Business Overview
Table 118. Advanced Orthopaedic Solutions Upper Extremities Disorders Treatment Product
Table 119. Advanced Orthopaedic Solutions Revenue in Upper Extremities Disorders Treatment Business (2016-2021) & (US$ Million)
Table 120. Advanced Orthopaedic Solutions Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Upper Extremities Disorders Treatment Market Share by Type: 2020 VS 2027
Figure 2. Replacement and Fracture Features
Figure 3. Nerve Diseases Features
Figure 4. Soft Issue Injuries Features
Figure 5. Global Upper Extremities Disorders Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals and Surgical Centers Case Studies
Figure 7. Orthopedic Surgical Centers Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Upper Extremities Disorders Treatment Report Years Considered
Figure 10. Global Upper Extremities Disorders Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Upper Extremities Disorders Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Upper Extremities Disorders Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Upper Extremities Disorders Treatment Market Share by Regions (2022-2027)
Figure 14. Global Upper Extremities Disorders Treatment Market Share by Players in 2020
Figure 15. Global Top Upper Extremities Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Upper Extremities Disorders Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Upper Extremities Disorders Treatment Revenue in 2020
Figure 17. Global Upper Extremities Disorders Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Upper Extremities Disorders Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Upper Extremities Disorders Treatment Market Share by Type (2016-2027)
Figure 21. North America Upper Extremities Disorders Treatment Market Share by Application (2016-2027)
Figure 22. North America Upper Extremities Disorders Treatment Market Share by Country (2016-2027)
Figure 23. United States Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Upper Extremities Disorders Treatment Market Share by Type (2016-2027)
Figure 27. Europe Upper Extremities Disorders Treatment Market Share by Application (2016-2027)
Figure 28. Europe Upper Extremities Disorders Treatment Market Share by Country (2016-2027)
Figure 29. Germany Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Upper Extremities Disorders Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Upper Extremities Disorders Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Upper Extremities Disorders Treatment Market Share by Region (2016-2027)
Figure 39. China Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Upper Extremities Disorders Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Upper Extremities Disorders Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Upper Extremities Disorders Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Upper Extremities Disorders Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Upper Extremities Disorders Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Upper Extremities Disorders Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Upper Extremities Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Integra LifeSciences Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2016-2021)
Figure 59. DePuy Synthes Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2016-2021)
Figure 60. Stryker Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2016-2021)
Figure 61. Zimmer Biomet Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2016-2021)
Figure 62. Smith and Nephew Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2016-2021)
Figure 63. Wright Medical Group N.V. Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2016-2021)
Figure 64. Exactech Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2016-2021)
Figure 65. Arthrex Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2016-2021)
Figure 66. CONMED Corporation Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2016-2021)
Figure 67. Acumed Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2016-2021)
Figure 68. Bioretec Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2016-2021)
Figure 69. Advanced Orthopaedic Solutions Revenue Growth Rate in Upper Extremities Disorders Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の上気道感染症治療市場規模・現状・予測（2021年-2027年）

Global Upper Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6058 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、上気道感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬 (NSAIDs) ＆鼻充血除去薬、その他）、用途別市場規模（鼻炎、副鼻腔炎、鼻咽頭炎、喉頭蓋炎、喉頭炎...

世界の尿素サイクル異常症（UCD）治療市場規模・現状・予測（2021年-2027年）

Global Urea Cycle Disorders (UCD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5000 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、尿素サイクル異常症（UCD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アミノ酸式、フェニル酪酸、安息香酸ナトリウム、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別...

世界の前頭側頭型認知症治療市場規模・現状・予測（2021年-2027年）

Global Frontotemporal Disorders Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4238 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、前頭側頭型認知症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（向知性薬、抗精神病薬、抗うつ薬、中枢神経刺激薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（...

世界のミトコンドリア病治療市場規模・現状・予測（2021年-2027年）

Global Mitochondrial Disorders Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5865 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ミトコンドリア病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ダイエット療法、ビタミン・サプリメント療法、パイプライン療法、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規...

世界の外傷＆四肢用機器市場規模・現状・予測（2021年-2027年）

Global Trauma And Extremities Devices Market Size, Status and Forecast 2021-2027
QFJ1-5368 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、外傷＆四肢用機器の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（頭蓋顔面装置、長骨刺激装置、その他外傷装置）、用途別市場規模（内部固定装置、外部固定装置）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の神経疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Neurologic Disorders Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4568 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、神経疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（中枢神経系（CNS）、末梢神経系（PNS））、用途別市場規模（麻痺、筋力低下、協調運動不全、感覚喪失、発作、錯乱、疼痛、意識レベル変化）、...

世界の女性性機能障害治療市場規模・現状・予測（2021年-2027年）

Global Female Sexual Dysfunction Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5740 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、女性性機能障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ホルモン療法、ホルモン療法）、用途別市場規模（性的欲求障害、性的覚醒障害、オルガスム障害、性的疼痛障害、オルガスム後疾患、骨盤底機能...

世界の遺伝性遺伝性疾患用遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy for Inherited Genetic Disorders Market Size, Status and Forecast 2021-2027
QFJ1-4248 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、遺伝性遺伝性疾患用遺伝子治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（眼疾患、造血系疾患、中枢神経系疾患、筋肉疾患、その他）、用途別市場規模（病院、診療所、研究所、その他）、主要地域別市場規模（...

世界のバイオパンクチャー治療市場規模・現状・予測（2021年-2027年）

Global Biopuncture Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5621 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、バイオパンクチャー治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルニカ、エキナセア、カモミール、その他）、用途別市場規模（婦人科系疾患、精神科系疾患、筋骨格系疾患、整形外科系疾患、消化器系疾患...

世界のリウマチ疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Rheumatic Disorders Drug Market Size, Status and Forecast 2021-2027
QFJ1-5995 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、リウマチ疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍壊死因子-α作用型、インターロイキン・インターロイキン受容体作用型、プロテインキナーゼ作用型、細胞表面抗原作用型、ホルモン・ホルモ...

世界の尿素サイクル異常症（UCD）治療市場規模・現状・予測（2021年-2027年） The urea cycle disorders are hereditary metabolic disorders caused by a deficiency of one of the enzymes in the urea cycle responsible for removing ammonia from the bloodstream. Market Analysis and Insights: Global Urea Cycle Disorders (UCD) Treatment Market The global Urea Cycle Disorders (UCD) Tre…
世界の上気道感染症治療市場規模・現状・予測（2021年-2027年） Rhinitis, sinusitis, nasopharyngitis, epiglottitis, laryngitis, and whooping cough are some of the types of upper respiratory tract infections. It can be treated with various drugs such as azithromycin, doxycycline, xylometazoline, propylhexedrine, amoxicillin, clarithromycin, aspirin, ibuprofen, er…
世界の前頭側頭型認知症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Frontotemporal Disorders Treatment Market The global Frontotemporal Disorders Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
世界の痔瘻非外科治療市場規模・現状・予測（2021年-2027年） Anal fistula treatment involves use of both surgical and non-surgical approaches for effective removal of anal fistulae in patients. Non-surgical methods include drugs as well as fibrin glue injections, adipose stem cell therapy, and collagen paste. Market Analysis and Insights: Global Anal Fistula …
世界の痔瘻外科治療市場規模・現状・予測（2021年-2027年） Anal fistula treatment involves use of both surgical and non-surgical approaches for effective removal of anal fistulae in patients. Surgical procedures include fistulotomy, bioprosthetic plugs, advancement flap procedures, seton techniques, and new techniques such as LIFT and FiLaC therapy. Market …